Profiel
Russell E.
Phares was a Director of Advanced Proteome Therapeutics Corp.
He served as Chief Executive Officer of CooperVision Pharmaceuticals and Cooper Laboratories for 10 years.
Dr. Phares received a PhD in Pharmacy from Purdue University.
He was an Assistant Professor of Pharmacy at the University of Florida.
Eerdere bekende functies van Russell E. Phares
| Bedrijven | Functie | Einde |
|---|---|---|
| ADVANCED PROTEOME THERAPEUTICS CORPORATION | Directeur/Bestuurslid | 11-10-2008 |
CooperVision, Inc.
 CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. | President | - |
| CooperVision Pharmaceuticals, Inc. | President | - |
Opleiding van Russell E. Phares
| Purdue University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ADVANCED PROTEOME THERAPEUTICS CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| CooperVision Pharmaceuticals, Inc. | |
CooperVision, Inc.
CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. | Health Technology |
